Group co-chairs issue a public statement regarding gender equity More Here
Patient-Reported Outcomes (PRO) Working Group webinar, Resources & Support for Integrating PROs in ECOG-ACRIN Studies, Thursday, June 17 from 12:00-1:00 pm EDT. Learn More and Register Here
Read the latest issue of our News from ECOG-ACRIN blog
The TMIST breast cancer screening trial continues to attract new sites and participants. Read the Q1 2021 site newsletter.
Cancer doesn’t stop for COVID, and neither should cancer screening or treatment Advocacy Blog
Our clinical trials are enrolling patients during the pandemic More Here
Question about COVID19? Send an email
New research results for patients with breast and HPV-associated throat cancers are the highlights among 23 presentations at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, June 4-8. ASCO will honor Joseph A. Sparano, MD. Read Press Release
A new study arm opens in NCI-MATCH, expanding patients’ potential to qualify for this precision medicine cancer clinical trial when they may not have other options. April 26, 2021 Read Press Release
Sara Hurvitz, MD, discusses the results of study E2108, which found that removal of the primary tumor in a person with de novo metastatic breast cancer did not improve survival. The E2108 data inform the use of systemic therapies. April 18, 2021. Cancer Network
Kevin Kalinsky, MD, discusses ways genetic assays such as those utilized in the TAILORx trial provide valuable insight to inform treatment decisions in patients with breast cancer. April 14, 2021. OncLive
An ad hoc advisory group formed by the National Cancer Institute recommends streamlining the currently-enrolling TMIST breast cancer screening trial. March 19, 2021 The Cancer Letter (subscription required)
View our YouTube channel for these and other videos:
Welcome to the ECOG-ACRIN Cancer Research Group website, the source of information about the cooperative group that was formed by the merger of the Eastern Cooperative Oncology Group (ECOG) and the American College of Radiology Imaging Network (ACRIN). We are excited to share news of our collaborative effort to design and conduct ground-breaking translational and clinical research.
The merger brought together the strengths and capabilities of two highly respected organizations. Since 1955, ECOG has performed practice-changing multicenter cancer clinical trials, working with more than 6000 physicians, nurses, pharmacists, statisticians, clinical research associates, and cancer research advocates from the United States and around the world. ACRIN, the premier imaging science program in the nation, complements ECOG’s research efforts with its expertise in early detection, imaging diagnosis, comparative-effectiveness research, and cost-effectiveness analysis. Now, as a single entity, we aim to achieve earlier cancer detection, more successful therapeutic intervention, higher rates of prevention, and better patient outcomes.
We look forward to sharing our research and partnering with you, as we reshape the future of patient care.
Robert L. Comis, MD